| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| Nectin-2 | HOTAvitag CD2-H82E7 | Biotinylated Human Nectin-2 / CD112 Protein, His,Avitag™ (MALS verified) |  Human | HEK293 |  | MALSSDS-PAGE | $360.00 25ug |   | |
| Nectin-2 | HOT PV2-H5253 | Human Nectin-2 / CD112 Protein, Fc Tag | Human | HEK293 |  | SDS-PAGE | $315.00 100ug | | |
| Nectin-2 | HOTAvitag CD2-H82F8 | Biotinylated Human Nectin-2 / CD112 Protein, Fc,Avitag™ (MALS verified) | Human | HEK293 |  | MALSSDS-PAGE | $360.00 25ug | | |
| Nectin-2 | HOT PV2-H52E2 | Human Nectin-2 / CD112 Protein, His Tag, low endotoxin (MALS verified) | Human | HEK293 |  | MALSSDS-PAGE | $325.00 100ug | | |
| Nectin-2 | Human Nectin-2 / CD112 Protein, Mouse IgG2a Fc Tag | Human | HEK293 |  | SDS-PAGE | $325.00 100ug | | ||
| Nectin-2 | Avitag CD2-H82A3 | Biotinylated Human Nectin-2 / CD112 Protein, Mouse IgG2a Fc,Avitag™ (MALS verified) | Human | HEK293 |  | MALSSDS-PAGE | $360.00 25ug | |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| COM-701 | COM-701 | Phase 2 Clinical | Compugen Ltd | Solid tumours; Head and Neck Neoplasms; Ovarian Neoplasms; Triple Negative Breast Neoplasms; Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Lung Neoplasms | Details |
| PM-1009 | PM1009 | Phase 2 Clinical | Liver Neoplasms; Solid tumours; Neoplasms; Lung Neoplasms; Carcinoma, Hepatocellular | Details | |
| SIM-0348 | SIM-0348 | Phase 1 Clinical | Simcere Pharmaceutical Group Ltd | Solid tumours; Neoplasms | Details |
| GSK-4381562 | SRF-813; GSK-4381562; GSK-4381562A; GSK4381562A; GSK’562 | Phase 1 Clinical | Surface Oncology Inc | Solid tumours; Neoplasms | Details |
| NM1F | NM1F; TGI-2 | Phase 1 Clinical | Hefei TG ImmunoPharma Co Ltd | Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms; Colorectal Neoplasms; Melanoma | Details |
| SHR-2002 | SHR-2002 | Phase 1 Clinical | Suzhou Suncadia Biopharmaceuticals Co Ltd, Shanghai Hengrui Pharmaceutical Co Ltd | Neoplasms | Details |
| JS-009 | JS009; TAB009; JS-009 | Phase 1 Clinical | Shanghai Junshi Biosciences Co Ltd | Solid tumours; Neoplasms | Details |
